151 related articles for article (PubMed ID: 11174738)
1. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
[TBL] [Abstract][Full Text] [Related]
2. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
Ovrum E; Am Holen E; Tangen G; Ringdal MA
Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
[TBL] [Abstract][Full Text] [Related]
3. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.
Aldea GS; Doursounian M; O'Gara P; Treanor P; Shapira OM; Lazar HL; Shemin RJ
Ann Thorac Surg; 1996 Aug; 62(2):410-7; discussion 417-8. PubMed ID: 8694599
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
7. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
[TBL] [Abstract][Full Text] [Related]
8. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
9. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits].
Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171
[TBL] [Abstract][Full Text] [Related]
10. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
11. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P
Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
[TBL] [Abstract][Full Text] [Related]
12. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction.
Ranucci M; Cirri S; Conti D; Ditta A; Boncilli A; Frigiola A; Menicanti L
Ann Thorac Surg; 1996 Jan; 61(1):76-81. PubMed ID: 8561642
[TBL] [Abstract][Full Text] [Related]
14. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass.
Weerwind PW; Maessen JG; van Tits LJ; Stad RK; Fransen EJ; de Jong DS; Penn OC
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1633-41. PubMed ID: 8523873
[TBL] [Abstract][Full Text] [Related]
15. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
16. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass.
Boonstra PW; Gu YJ; Akkerman C; Haan J; Huyzen R; van Oeveren W
J Thorac Cardiovasc Surg; 1994 Jan; 107(1):289-92. PubMed ID: 8283898
[TBL] [Abstract][Full Text] [Related]
17. Clinical heparin coated cardiopulmonary bypass: reduction of systemic heparin requirements for redo cardiac surgery.
Ladowski JS; Schatzlein MH; Peterson AC; Deschner WP; Matheis R; Ellenwood M; Bach J; Moldovan L; McKamey D
ASAIO J; 1996; 42(1):34-6. PubMed ID: 8808455
[TBL] [Abstract][Full Text] [Related]
18. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support.
von Segesser LK
Ann Thorac Surg; 1996 Jan; 61(1):330-5; discussion 340-1. PubMed ID: 8561600
[TBL] [Abstract][Full Text] [Related]
19. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE
J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits.
Tong SD; Rolfs MR; Hsu LC
ASAIO Trans; 1990; 36(3):M654-6. PubMed ID: 2252775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
